🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

Within minutes of joining one community, a vendor shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Within these communities, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially serious health risks”.